Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
Department of Diagnostic Radiology, Singapore General Hospital, Singapore.
Am J Sports Med. 2021 Jun;49(7):1854-1860. doi: 10.1177/03635465211010158. Epub 2021 May 6.
In a study from our institution, ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon for recalcitrant lateral elbow tendinopathy showed excellent safety profiles, high tolerability, efficiency, sustained pain relief, functional improvement, and sonographic evidence of tissue healing in 20 patients at 3 years' follow-up.
To explore the long-term clinical and sonographic results of ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon.
Case series; Level of evidence, 4.
The same cohort of 20 patients was recalled after 7 years, and visual analog scale (VAS) for pain and Disabilities of the Arm, Shoulder and Hand (DASH) scores, need for secondary intervention, and overall satisfaction were assessed. They were also reassessed using ultrasound imaging of the brevis and the common extensor tendon to evaluate tendon hypervascularity, tendon thickness, and the progress or the recurrence of the hypoechoic scar tissue.
We successfully scored 19 patients and performed ultrasound on 16 patients with a median follow-up of 90 months (range, 86-102 months). There were no adverse outcomes and satisfaction remained at 100% (6 patients, satisfied; 13 patients, very satisfied). No patient developed a recurrence of symptoms and signs of lateral elbow tendinopathy, and therefore no secondary intervention was required. The improvement from baseline and early term scores was sustained ( < .001 for all). At 90 months, there was a significant improvement in VAS scores and DASH-Compulsory scores compared with preprocedure scores and all follow-up times until 3 months. There was no difference in VAS scores and DASH-Compulsory scores at 90 months compared with 6 and 36 months. For DASH-Work scores, there was a significant improvement at 90 months compared with preprocedure scores, but there was no difference between DASH-Work scores at 90 months and scores at all other points of follow-up. At 90 months, hypervascularity remained resolved in 79% of patients, while all patients had reduced tendon swelling and sustained resolution or reduction of the hypoechoic lesion.
At the long-term follow-up of 90 months, ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon, previously shown to enhance recovery of lateral elbow tendinopathy, demonstrated good durability of pain relief and functional recovery that was previously achieved. This was accompanied by sustained sonographic tissue healing with no significant deterioration.
在我们机构的一项研究中,超声经皮短伸肌腱和指总伸肌腱切开术治疗顽固性肘外侧肌腱病显示出极好的安全性、高耐受性、有效性、持续缓解疼痛、功能改善和组织愈合的超声证据,20 例患者在 3 年随访时得到了证实。
探讨超声经皮短伸肌腱和指总伸肌腱切开术的长期临床和超声结果。
病例系列;证据水平,4 级。
对 20 例患者进行了 7 年的随访,评估了视觉模拟评分(VAS)疼痛和上肢残疾程度(DASH)评分、需要二次干预和总体满意度。对 16 例患者进行了超声检查,评估了短伸肌腱和指总伸肌腱的肌腱高血管化、肌腱厚度以及低回声瘢痕组织的进展或复发情况。
我们成功评分了 19 例患者,并对 16 例患者进行了超声检查,中位随访时间为 90 个月(范围,86-102 个月)。无不良结局,满意度为 100%(6 例患者满意;13 例患者非常满意)。无患者出现外侧肘肌腱病的症状和体征复发,因此无需进行二次干预。从基线和早期评分的改善是持续的(所有均<.001)。90 个月时,VAS 评分和 DASH-Compulsory 评分与术前评分和所有随访时间至 3 个月相比均有显著改善。90 个月时 VAS 评分和 DASH-Compulsory 评分与 6 个月和 36 个月时无差异。对于 DASH-Work 评分,与术前评分相比,90 个月时有显著改善,但 90 个月时的 DASH-Work 评分与所有其他随访时间点的评分无差异。90 个月时,79%的患者肌腱高血管化仍得到缓解,所有患者的肌腱肿胀减轻,低回声病变持续缓解或减少。
在 90 个月的长期随访中,超声经皮短伸肌腱和指总伸肌腱切开术,以前被证明可以促进外侧肘肌腱病的恢复,显示出良好的疼痛缓解和功能恢复的持久性,以前达到的效果。同时,超声显示组织愈合持续,无明显恶化。